ArticleBiomedicines2023

Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS).

Jean-Louis Merlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.